Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development

Journal of the Society for Gynecologic Investigation

Volumn 11, Issue 5, 2004, Pages 329-337

  Lea, Jayanthi S ^a   Ashfaq, Raheela ^a   Muneer, Sabeeha ^a   Burbee, David G ^a   Miller, David S ^a   Minna, John D ^a   Muller, Carolyn Y ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

aberrant methylation; FHIT, cervical cancer

Indexed keywords

DNA; FRAGILE HISTIDINE TRIAD PROTEIN; RNA; TUMOR MARKER;

ALLELE; ARTICLE; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DETERMINATION; EXON; FEMALE; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; UTERINE CERVIX CANCER; WESTERN BLOTTING; WILD TYPE;

ACID ANHYDRIDE HYDROLASES; BASE SEQUENCE; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; FEMALE; HELA CELLS; HUMANS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 3042637842     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2003.12.008     Document Type: Article

References (18)

1. Hoskins W.J., Perez C.A., Young R.C. Principles and practice of gynecologic oncology. 1997;Lippincott Raven Publishers, Philadelphia
2. Yokota J., Tsuka Y., Nakajima T., et al. Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res. 49:1989;3598-3601
3. Wistuba I.I., Montellano F.D., Milchgrub S., et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res. 57:1997;3154-3158
4. Connolly D., Greenspan D.L., Wu R., et al. Loss of fhit expression in invasive cervical carcinomas and intra-epithelial lesions associated with invasive disease. Clin Cancer Res. 9:2000;3505-3510
5. Sozzi G., Tornialli S., Tagliabue E., et al. Absence of FHIT protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res. 57:1997;5207-5212
6. Tanaka H, Shimada Y, Harada H, et al. Methylation of the 5 CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 1998;58:3429-34
7. Muller C.Y., O'Boyle J.D., Fong K.M., et al. Abnormalities of fragile histidine triad genomic and complementary DNAs in cervical cancer Association with human papillomavirus type. J Natl Cancer Inst. 6:1998;433-439
8. Huebner K., Garrison P.N., Barnes L.D., Croce C.M. The role of the FHIT/FRA3B locus in cancer. Annu Rev Genet. 32:1998;7-31
9. Barnes L.D., Garrison P.N., Siprashvili Z., et al. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5, 5″ -p1, p3- triphosphate hydrolase. Biochemistry. 35:1996;11529-11535
10. Birrer M.J., Hendricks D., Farley J., et al. Abnormal Fhit expression in malignant and premalignant lesions of the cervix. Cancer Res. 59:1999;5270-5274
11. Yoshino K., Enomoto T., Nakamura T., et al. Fhit alterations in cancerous and non-cancerous cervical epithelium. Int J Cancer. 85:2000;6-13
12. Wu R., Connolly C., Dunn R.L., Cho K.R. Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells. J Natl Cancer Inst. 4:2000;338-344
13. Greenspan D.L., Connolly D.C., Wu R., et al. Loss of Fhit expression in cervical carcinoma cell lines and primary tumors. Cancer Res. 57:1997;4692-4698
14. Zochbauer-Muller S., Fong K.M., Maitra A., et al. 5CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer. Cancer Res. 61:2001;3581-3585
15. Virmani A.K., Muller C.Y., Rathi A., Zoechbauer-Mueller S., Mathis M., Gazdar A.F. Aberrant methylation during cervical carcinogenesis. Clin Cancer Res. 7:2001;584-589
16. Fong K.W., Biesterveld E.J., Virmani A., et al. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer related FHIT cDNA splicing abberations. Cancer Res. 57:1997;2256-2267
17. Thiagalingam S., Lisitsyn A., Hamaguchi M., et al. Evaluation of the FHIT gene in colorectal cancers. Cancer Res. 56:1997;2936-2939
18. Lin W.M., Michalopulos E.A., Dhurander N., et al. Allelic loss and microsatellite alterations of chromosome 3p14.2 are more frequent in recurrent cervical dysplasias. Clin Cancer Res. 4:2000;1410-1414